APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biobanking Sample

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biobanking Sample Market Outlook and Growth Opportunities 2026

26 December 2025201 pages

Choose your research edition.

Industry ResearchBiobanking Sample Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Biobanking Sample Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Biobanking Sample Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biobanking Sample Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Biobanking Sample Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Biobanking Sample market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biobanking Sample market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biobanking Sample market include Becton, Dickinson and Company (US), Biokryo GmbH (Germany), Brooks Automation (US), Chart Industries (US), Greiner Bio One [Greiner Holding AG, Austria)], Hamilton Company (US), LVL Technologies GmbH & Co. KG (Germany), Micronic (Netherlands) and Panasonic Healthcare Holdings Co. Ltd (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biobanking Sample market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biobanking Sample and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biobanking Sample sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biobanking Sample market size, projected growth trends, production technologies, key applications, and end-use industries.

Biobanking Sample Segment by Company

Becton, Dickinson and Company (US)

Biokryo GmbH (Germany)

Brooks Automation (US)

Chart Industries (US)

Greiner Bio One [Greiner Holding AG, Austria)]

Hamilton Company (US)

LVL Technologies GmbH & Co. KG (Germany)

Micronic (Netherlands)

Panasonic Healthcare Holdings Co. Ltd (Japan)

Promega Corporation (US)

Qiagen N.V. (Germany)

Tecan Group Ltd. (Switzerland)

TTP Labtech Ltd (U.K.)

VWR Corporation (US)

Worthington Industries [(Taylor Wharton, US)]

Merck KGaA (Germany)

Thermo Fisher Scientific Inc(US)

Biobanking Sample Segment by Type

Nucleic Acids

Human Waste Products

Human Tissues

Biological Fluids

Cell Lines

Blood Products

Biobanking Sample Segment by Application

Clinical Research

Life Science Research

Regenerative Medicine

Biobanking Sample Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biobanking Sample status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biobanking Sample market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biobanking Sample significant trends, drivers, influence factors in global and regions.

6. To analyze Biobanking Sample competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking Sample market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biobanking Sample and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking Sample.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biobanking Sample market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biobanking Sample industry.

Chapter 3: Detailed analysis of Biobanking Sample manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biobanking Sample in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biobanking Sample in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biobanking Sample Industry Trends Table 2. Biobanking Sample Industry Drivers Table 3. Biobanking Sample Industry Opportunities and Challenges Table 4. Biobanking Sample Industry Restraints Table 5. Global Biobanking Sample Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biobanking Sample Revenue Share by Company (2021-2026) Table 7. Global Biobanking Sample Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Biobanking Sample Sales Volume Share by Company (2021-2026) Table 9. Global Biobanking Sample Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Biobanking Sample Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biobanking Sample Key Company Manufacturing Base & Headquarters Table 12. Global Biobanking Sample Company, Product Type & Application Table 13. Global Biobanking Sample Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biobanking Sample by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nucleic Acids Table 18. Significant Companies of Human Waste Products Table 19. Significant Companies of Human Tissues Table 20. Significant Companies of Biological Fluids Table 21. Significant Companies of Cell Lines Table 22. Significant Companies of Blood Products Table 23. Global Biobanking Sample Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Biobanking Sample Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Biobanking Sample Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Biobanking Sample Sales Volume Share by Type (2021-2026) Table 27. Global Biobanking Sample Sales Volume Share by Type (2027-2032) Table 28. Global Biobanking Sample Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biobanking Sample Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Biobanking Sample Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Biobanking Sample Sales Value Share by Type (2021-2026) Table 32. Global Biobanking Sample Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Clinical Research Table 34. Significant Companies of Life Science Research Table 35. Significant Companies of Regenerative Medicine Table 36. Global Biobanking Sample Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Biobanking Sample Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Biobanking Sample Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Biobanking Sample Sales Volume Share by Application (2021-2026) Table 40. Global Biobanking Sample Sales Volume Share by Application (2027-2032) Table 41. Global Biobanking Sample Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Biobanking Sample Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Biobanking Sample Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Biobanking Sample Sales Value Share by Application (2021-2026) Table 45. Global Biobanking Sample Sales Value Share by Application (2027-2032) Table 46. Global Biobanking Sample Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Biobanking Sample Sales by Region (2021-2026) & (K Units) Table 48. Global Biobanking Sample Sales Market Share by Region (2021-2026) Table 49. Global Biobanking Sample Sales by Region (2027-2032) & (K Units) Table 50. Global Biobanking Sample Sales Market Share by Region (2027-2032) Table 51. Global Biobanking Sample Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Biobanking Sample Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Biobanking Sample Sales Value Share by Region (2021-2026) Table 54. Global Biobanking Sample Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Biobanking Sample Sales Value Share by Region (2027-2032) Table 56. Global Biobanking Sample Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Biobanking Sample Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Biobanking Sample Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Biobanking Sample Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Biobanking Sample Sales by Country (2021-2026) & (K Units) Table 61. Global Biobanking Sample Sales Market Share by Country (2021-2026) Table 62. Global Biobanking Sample Sales by Country (2027-2032) & (K Units) Table 63. Global Biobanking Sample Sales Market Share by Country (2027-2032) Table 64. Global Biobanking Sample Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Biobanking Sample Sales Value Market Share by Country (2021-2026) Table 66. Global Biobanking Sample Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Biobanking Sample Sales Value Market Share by Country (2027-2032) Table 68. Becton, Dickinson and Company (US) Company Information Table 69. Becton, Dickinson and Company (US) Business Overview Table 70. Becton, Dickinson and Company (US) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Becton, Dickinson and Company (US) Biobanking Sample Product Portfolio Table 72. Becton, Dickinson and Company (US) Recent Development Table 73. Biokryo GmbH (Germany) Company Information Table 74. Biokryo GmbH (Germany) Business Overview Table 75. Biokryo GmbH (Germany) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Biokryo GmbH (Germany) Biobanking Sample Product Portfolio Table 77. Biokryo GmbH (Germany) Recent Development Table 78. Brooks Automation (US) Company Information Table 79. Brooks Automation (US) Business Overview Table 80. Brooks Automation (US) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Brooks Automation (US) Biobanking Sample Product Portfolio Table 82. Brooks Automation (US) Recent Development Table 83. Chart Industries (US) Company Information Table 84. Chart Industries (US) Business Overview Table 85. Chart Industries (US) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Chart Industries (US) Biobanking Sample Product Portfolio Table 87. Chart Industries (US) Recent Development Table 88. Greiner Bio One [Greiner Holding AG, Austria)] Company Information Table 89. Greiner Bio One [Greiner Holding AG, Austria)] Business Overview Table 90. Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Product Portfolio Table 92. Greiner Bio One [Greiner Holding AG, Austria)] Recent Development Table 93. Hamilton Company (US) Company Information Table 94. Hamilton Company (US) Business Overview Table 95. Hamilton Company (US) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hamilton Company (US) Biobanking Sample Product Portfolio Table 97. Hamilton Company (US) Recent Development Table 98. LVL Technologies GmbH & Co. KG (Germany) Company Information Table 99. LVL Technologies GmbH & Co. KG (Germany) Business Overview Table 100. LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Product Portfolio Table 102. LVL Technologies GmbH & Co. KG (Germany) Recent Development Table 103. Micronic (Netherlands) Company Information Table 104. Micronic (Netherlands) Business Overview Table 105. Micronic (Netherlands) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Micronic (Netherlands) Biobanking Sample Product Portfolio Table 107. Micronic (Netherlands) Recent Development Table 108. Panasonic Healthcare Holdings Co. Ltd (Japan) Company Information Table 109. Panasonic Healthcare Holdings Co. Ltd (Japan) Business Overview Table 110. Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Product Portfolio Table 112. Panasonic Healthcare Holdings Co. Ltd (Japan) Recent Development Table 113. Promega Corporation (US) Company Information Table 114. Promega Corporation (US) Business Overview Table 115. Promega Corporation (US) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Promega Corporation (US) Biobanking Sample Product Portfolio Table 117. Promega Corporation (US) Recent Development Table 118. Qiagen N.V. (Germany) Company Information Table 119. Qiagen N.V. (Germany) Business Overview Table 120. Qiagen N.V. (Germany) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Qiagen N.V. (Germany) Biobanking Sample Product Portfolio Table 122. Qiagen N.V. (Germany) Recent Development Table 123. Tecan Group Ltd. (Switzerland) Company Information Table 124. Tecan Group Ltd. (Switzerland) Business Overview Table 125. Tecan Group Ltd. (Switzerland) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Tecan Group Ltd. (Switzerland) Biobanking Sample Product Portfolio Table 127. Tecan Group Ltd. (Switzerland) Recent Development Table 128. TTP Labtech Ltd (U.K.) Company Information Table 129. TTP Labtech Ltd (U.K.) Business Overview Table 130. TTP Labtech Ltd (U.K.) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. TTP Labtech Ltd (U.K.) Biobanking Sample Product Portfolio Table 132. TTP Labtech Ltd (U.K.) Recent Development Table 133. VWR Corporation (US) Company Information Table 134. VWR Corporation (US) Business Overview Table 135. VWR Corporation (US) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. VWR Corporation (US) Biobanking Sample Product Portfolio Table 137. VWR Corporation (US) Recent Development Table 138. Worthington Industries [(Taylor Wharton, US)] Company Information Table 139. Worthington Industries [(Taylor Wharton, US)] Business Overview Table 140. Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Product Portfolio Table 142. Worthington Industries [(Taylor Wharton, US)] Recent Development Table 143. Merck KGaA (Germany) Company Information Table 144. Merck KGaA (Germany) Business Overview Table 145. Merck KGaA (Germany) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Merck KGaA (Germany) Biobanking Sample Product Portfolio Table 147. Merck KGaA (Germany) Recent Development Table 148. Thermo Fisher Scientific Inc(US) Company Information Table 149. Thermo Fisher Scientific Inc(US) Business Overview Table 150. Thermo Fisher Scientific Inc(US) Biobanking Sample Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Thermo Fisher Scientific Inc(US) Biobanking Sample Product Portfolio Table 152. Thermo Fisher Scientific Inc(US) Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Biobanking Sample Distributors List Table 156. Biobanking Sample Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Biobanking Sample Product Image Figure 2. Global Biobanking Sample Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biobanking Sample Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biobanking Sample Sales (2021-2032) & (K Units) Figure 5. Global Biobanking Sample Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Biobanking Sample Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nucleic Acids Image Figure 10. Human Waste Products Image Figure 11. Human Tissues Image Figure 12. Biological Fluids Image Figure 13. Cell Lines Image Figure 14. Blood Products Image Figure 15. Global Biobanking Sample Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Biobanking Sample Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Biobanking Sample Sales Volume Share by Type (2021-2032) Figure 18. Global Biobanking Sample Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biobanking Sample Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Biobanking Sample Sales Value Share by Type (2021-2032) Figure 21. Clinical Research Image Figure 22. Life Science Research Image Figure 23. Regenerative Medicine Image Figure 24. Global Biobanking Sample Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Biobanking Sample Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Biobanking Sample Sales Volume Share by Application (2021-2032) Figure 27. Global Biobanking Sample Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Biobanking Sample Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Biobanking Sample Sales Value Share by Application (2021-2032) Figure 30. Global Biobanking Sample Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Biobanking Sample Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Biobanking Sample Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Biobanking Sample Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Biobanking Sample Sales Value (2021-2032) & (US$ Million) Figure 35. North America Biobanking Sample Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Biobanking Sample Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Biobanking Sample Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Biobanking Sample Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Biobanking Sample Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Biobanking Sample Sales Value (2021-2032) & (US$ Million) Figure 41. South America Biobanking Sample Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Biobanking Sample Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Biobanking Sample Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Biobanking Sample Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Biobanking Sample Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Biobanking Sample Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Biobanking Sample Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Biobanking Sample Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleic Acids
  • Human Waste Products
  • Human Tissues
  • Biological Fluids
  • Cell Lines
  • Blood Products
Applications
  • Clinical Research
  • Life Science Research
  • Regenerative Medicine
Companies covered
  • Becton, Dickinson and Company (US)
  • Biokryo GmbH (Germany)
  • Brooks Automation (US)
  • Chart Industries (US)
  • Greiner Bio One [Greiner Holding AG, Austria)]
  • Hamilton Company (US)
  • LVL Technologies GmbH & Co. KG (Germany)
  • Micronic (Netherlands)
  • Panasonic Healthcare Holdings Co. Ltd (Japan)
  • Promega Corporation (US)
  • Qiagen N.V. (Germany)
  • Tecan Group Ltd. (Switzerland)
  • TTP Labtech Ltd (U.K.)
  • VWR Corporation (US)
  • Worthington Industries [(Taylor Wharton, US)]
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific Inc(US)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biobanking Sample Sales Value (2021-2032)
  4. 1.2.2 Global Biobanking Sample Sales Volume (2021-2032)
  5. 1.2.3 Global Biobanking Sample Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biobanking Sample Market Dynamics
  1. 2.1 Biobanking Sample Industry Trends
  2. 2.2 Biobanking Sample Industry Drivers
  3. 2.3 Biobanking Sample Industry Opportunities and Challenges
  4. 2.4 Biobanking Sample Industry Restraints
3 Biobanking Sample Market by Company
  1. 3.1 Global Biobanking Sample Company Revenue Ranking in 2025
  2. 3.2 Global Biobanking Sample Revenue by Company (2021-2026)
  3. 3.3 Global Biobanking Sample Sales Volume by Company (2021-2026)
  4. 3.4 Global Biobanking Sample Average Price by Company (2021-2026)
  5. 3.5 Global Biobanking Sample Company Ranking (2024-2026)
  6. 3.6 Global Biobanking Sample Company Manufacturing Base and Headquarters
  7. 3.7 Global Biobanking Sample Company Product Type and Application
  8. 3.8 Global Biobanking Sample Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biobanking Sample Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biobanking Sample Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biobanking Sample Market by Type
  1. 4.1 Biobanking Sample Type Introduction
  2. 4.1.1 Nucleic Acids
  3. 4.1.2 Human Waste Products
  4. 4.1.3 Human Tissues
  5. 4.1.4 Biological Fluids
  6. 4.1.5 Cell Lines
  7. 4.1.6 Blood Products
  8. 4.2 Global Biobanking Sample Sales Volume by Type
  9. 4.2.1 Global Biobanking Sample Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Biobanking Sample Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Biobanking Sample Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Biobanking Sample Sales Value by Type
  13. 4.3.1 Global Biobanking Sample Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Biobanking Sample Sales Value by Type (2021-2032)
  15. 4.3.3 Global Biobanking Sample Sales Value Share by Type (2021-2032)
5 Biobanking Sample Market by Application
  1. 5.1 Biobanking Sample Application Introduction
  2. 5.1.1 Clinical Research
  3. 5.1.2 Life Science Research
  4. 5.1.3 Regenerative Medicine
  5. 5.2 Global Biobanking Sample Sales Volume by Application
  6. 5.2.1 Global Biobanking Sample Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biobanking Sample Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Biobanking Sample Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Biobanking Sample Sales Value by Application
  10. 5.3.1 Global Biobanking Sample Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Biobanking Sample Sales Value by Application (2021-2032)
  12. 5.3.3 Global Biobanking Sample Sales Value Share by Application (2021-2032)
6 Biobanking Sample Regional Sales and Value Analysis
  1. 6.1 Global Biobanking Sample Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biobanking Sample Sales by Region (2021-2032)
  3. 6.2.1 Global Biobanking Sample Sales by Region: 2021-2026
  4. 6.2.2 Global Biobanking Sample Sales by Region (2027-2032)
  5. 6.3 Global Biobanking Sample Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biobanking Sample Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biobanking Sample Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biobanking Sample Sales Value by Region (2027-2032)
  9. 6.5 Global Biobanking Sample Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biobanking Sample Sales Value (2021-2032)
  12. 6.6.2 North America Biobanking Sample Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biobanking Sample Sales Value (2021-2032)
  15. 6.7.2 Europe Biobanking Sample Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biobanking Sample Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biobanking Sample Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biobanking Sample Sales Value (2021-2032)
  21. 6.9.2 South America Biobanking Sample Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biobanking Sample Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biobanking Sample Sales Value Share by Country, 2025 VS 2032
7 Biobanking Sample Country-level Sales and Value Analysis
  1. 7.1 Global Biobanking Sample Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biobanking Sample Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biobanking Sample Sales by Country (2021-2032)
  4. 7.3.1 Global Biobanking Sample Sales by Country (2021-2026)
  5. 7.3.2 Global Biobanking Sample Sales by Country (2027-2032)
  6. 7.4 Global Biobanking Sample Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biobanking Sample Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biobanking Sample Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biobanking Sample Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biobanking Sample Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biobanking Sample Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biobanking Sample Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biobanking Sample Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biobanking Sample Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biobanking Sample Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biobanking Sample Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biobanking Sample Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biobanking Sample Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biobanking Sample Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biobanking Sample Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biobanking Sample Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biobanking Sample Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biobanking Sample Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biobanking Sample Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biobanking Sample Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biobanking Sample Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biobanking Sample Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biobanking Sample Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biobanking Sample Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biobanking Sample Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biobanking Sample Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biobanking Sample Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biobanking Sample Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biobanking Sample Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biobanking Sample Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biobanking Sample Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biobanking Sample Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biobanking Sample Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biobanking Sample Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Becton, Dickinson and Company (US)
  2. 8.1.1 Becton, Dickinson and Company (US) Company Information
  3. 8.1.2 Becton, Dickinson and Company (US) Business Overview
  4. 8.1.3 Becton, Dickinson and Company (US) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Becton, Dickinson and Company (US) Biobanking Sample Product Portfolio
  6. 8.1.5 Becton, Dickinson and Company (US) Recent Developments
  7. 8.2 Biokryo GmbH (Germany)
  8. 8.2.1 Biokryo GmbH (Germany) Company Information
  9. 8.2.2 Biokryo GmbH (Germany) Business Overview
  10. 8.2.3 Biokryo GmbH (Germany) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biokryo GmbH (Germany) Biobanking Sample Product Portfolio
  12. 8.2.5 Biokryo GmbH (Germany) Recent Developments
  13. 8.3 Brooks Automation (US)
  14. 8.3.1 Brooks Automation (US) Company Information
  15. 8.3.2 Brooks Automation (US) Business Overview
  16. 8.3.3 Brooks Automation (US) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Brooks Automation (US) Biobanking Sample Product Portfolio
  18. 8.3.5 Brooks Automation (US) Recent Developments
  19. 8.4 Chart Industries (US)
  20. 8.4.1 Chart Industries (US) Company Information
  21. 8.4.2 Chart Industries (US) Business Overview
  22. 8.4.3 Chart Industries (US) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chart Industries (US) Biobanking Sample Product Portfolio
  24. 8.4.5 Chart Industries (US) Recent Developments
  25. 8.5 Greiner Bio One [Greiner Holding AG, Austria)]
  26. 8.5.1 Greiner Bio One [Greiner Holding AG, Austria)] Company Information
  27. 8.5.2 Greiner Bio One [Greiner Holding AG, Austria)] Business Overview
  28. 8.5.3 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Product Portfolio
  30. 8.5.5 Greiner Bio One [Greiner Holding AG, Austria)] Recent Developments
  31. 8.6 Hamilton Company (US)
  32. 8.6.1 Hamilton Company (US) Company Information
  33. 8.6.2 Hamilton Company (US) Business Overview
  34. 8.6.3 Hamilton Company (US) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hamilton Company (US) Biobanking Sample Product Portfolio
  36. 8.6.5 Hamilton Company (US) Recent Developments
  37. 8.7 LVL Technologies GmbH & Co. KG (Germany)
  38. 8.7.1 LVL Technologies GmbH & Co. KG (Germany) Company Information
  39. 8.7.2 LVL Technologies GmbH & Co. KG (Germany) Business Overview
  40. 8.7.3 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Product Portfolio
  42. 8.7.5 LVL Technologies GmbH & Co. KG (Germany) Recent Developments
  43. 8.8 Micronic (Netherlands)
  44. 8.8.1 Micronic (Netherlands) Company Information
  45. 8.8.2 Micronic (Netherlands) Business Overview
  46. 8.8.3 Micronic (Netherlands) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Micronic (Netherlands) Biobanking Sample Product Portfolio
  48. 8.8.5 Micronic (Netherlands) Recent Developments
  49. 8.9 Panasonic Healthcare Holdings Co. Ltd (Japan)
  50. 8.9.1 Panasonic Healthcare Holdings Co. Ltd (Japan) Company Information
  51. 8.9.2 Panasonic Healthcare Holdings Co. Ltd (Japan) Business Overview
  52. 8.9.3 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Product Portfolio
  54. 8.9.5 Panasonic Healthcare Holdings Co. Ltd (Japan) Recent Developments
  55. 8.10 Promega Corporation (US)
  56. 8.10.1 Promega Corporation (US) Company Information
  57. 8.10.2 Promega Corporation (US) Business Overview
  58. 8.10.3 Promega Corporation (US) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Promega Corporation (US) Biobanking Sample Product Portfolio
  60. 8.10.5 Promega Corporation (US) Recent Developments
  61. 8.11 Qiagen N.V. (Germany)
  62. 8.11.1 Qiagen N.V. (Germany) Company Information
  63. 8.11.2 Qiagen N.V. (Germany) Business Overview
  64. 8.11.3 Qiagen N.V. (Germany) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Qiagen N.V. (Germany) Biobanking Sample Product Portfolio
  66. 8.11.5 Qiagen N.V. (Germany) Recent Developments
  67. 8.12 Tecan Group Ltd. (Switzerland)
  68. 8.12.1 Tecan Group Ltd. (Switzerland) Company Information
  69. 8.12.2 Tecan Group Ltd. (Switzerland) Business Overview
  70. 8.12.3 Tecan Group Ltd. (Switzerland) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Tecan Group Ltd. (Switzerland) Biobanking Sample Product Portfolio
  72. 8.12.5 Tecan Group Ltd. (Switzerland) Recent Developments
  73. 8.13 TTP Labtech Ltd (U.K.)
  74. 8.13.1 TTP Labtech Ltd (U.K.) Company Information
  75. 8.13.2 TTP Labtech Ltd (U.K.) Business Overview
  76. 8.13.3 TTP Labtech Ltd (U.K.) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 TTP Labtech Ltd (U.K.) Biobanking Sample Product Portfolio
  78. 8.13.5 TTP Labtech Ltd (U.K.) Recent Developments
  79. 8.14 VWR Corporation (US)
  80. 8.14.1 VWR Corporation (US) Company Information
  81. 8.14.2 VWR Corporation (US) Business Overview
  82. 8.14.3 VWR Corporation (US) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 VWR Corporation (US) Biobanking Sample Product Portfolio
  84. 8.14.5 VWR Corporation (US) Recent Developments
  85. 8.15 Worthington Industries [(Taylor Wharton, US)]
  86. 8.15.1 Worthington Industries [(Taylor Wharton, US)] Company Information
  87. 8.15.2 Worthington Industries [(Taylor Wharton, US)] Business Overview
  88. 8.15.3 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Product Portfolio
  90. 8.15.5 Worthington Industries [(Taylor Wharton, US)] Recent Developments
  91. 8.16 Merck KGaA (Germany)
  92. 8.16.1 Merck KGaA (Germany) Company Information
  93. 8.16.2 Merck KGaA (Germany) Business Overview
  94. 8.16.3 Merck KGaA (Germany) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Merck KGaA (Germany) Biobanking Sample Product Portfolio
  96. 8.16.5 Merck KGaA (Germany) Recent Developments
  97. 8.17 Thermo Fisher Scientific Inc(US)
  98. 8.17.1 Thermo Fisher Scientific Inc(US) Company Information
  99. 8.17.2 Thermo Fisher Scientific Inc(US) Business Overview
  100. 8.17.3 Thermo Fisher Scientific Inc(US) Biobanking Sample Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Thermo Fisher Scientific Inc(US) Biobanking Sample Product Portfolio
  102. 8.17.5 Thermo Fisher Scientific Inc(US) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biobanking Sample Value Chain Analysis
  2. 9.1.1 Biobanking Sample Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biobanking Sample Sales Mode & Process
  6. 9.2 Biobanking Sample Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biobanking Sample Distributors
  9. 9.2.3 Biobanking Sample Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst